Buy this little-known pharma stock with more than 80% upside ahead, RBC says
Post date: 2024-04-23 04:56:07
Views: 15
Analyst Luca Issi began research coverage of the pharmaceutical company, which develops treatments for rare and ultra-rare diseases, with an outperform rating.